SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $1,110,000 | -43.8% | 415,765 | 0.0% | 0.48% | -58.5% |
Q1 2019 | $1,975,000 | +97.9% | 415,765 | 0.0% | 1.16% | +76.5% |
Q4 2018 | $998,000 | -45.4% | 415,765 | 0.0% | 0.66% | -53.5% |
Q3 2018 | $1,829,000 | -38.9% | 415,765 | 0.0% | 1.41% | -38.4% |
Q2 2018 | $2,994,000 | +39.8% | 415,765 | 0.0% | 2.29% | +29.7% |
Q1 2018 | $2,141,000 | -67.6% | 415,765 | -76.1% | 1.77% | -74.9% |
Q4 2017 | $6,605,000 | +38.8% | 1,738,232 | -37.9% | 7.03% | +722.8% |
Q3 2017 | $4,760,000 | -15.0% | 2,799,790 | 0.0% | 0.85% | -42.6% |
Q2 2017 | $5,599,000 | -49.4% | 2,799,790 | 0.0% | 1.49% | -57.5% |
Q1 2017 | $11,059,000 | -19.4% | 2,799,790 | 0.0% | 3.50% | -44.5% |
Q4 2016 | $13,719,000 | -36.7% | 2,799,790 | 0.0% | 6.31% | -3.4% |
Q3 2016 | $21,671,000 | +38.2% | 2,799,790 | 0.0% | 6.53% | +10.5% |
Q2 2016 | $15,678,000 | +11.1% | 2,799,790 | +6.7% | 5.91% | +20.4% |
Q1 2016 | $14,115,000 | -38.2% | 2,623,533 | 0.0% | 4.91% | -23.9% |
Q4 2015 | $22,851,000 | +59.2% | 2,623,533 | +53.3% | 6.45% | +20.3% |
Q3 2015 | $14,355,000 | +10.7% | 1,711,063 | +132.5% | 5.36% | +20.6% |
Q2 2015 | $12,968,000 | – | 736,012 | – | 4.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
EMFO, LLC | 209,398 | $185,527 | 0.19% |
Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
Mayo Clinic | 300,000 | $267,000 | 0.14% |
swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |